- Home
- FTFT vs APVO Comparison
FTFT vs APVO Comparison
Compare FTFT & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- APVO
- Stock Information
- Founded
- FTFT N/A
- APVO 2016
- Country
- FTFT United States
- APVO United States
- Employees
- FTFT N/A
- APVO N/A
- Industry
- FTFT Business Services
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- APVO Health Care
- Exchange
- FTFT Nasdaq
- APVO Nasdaq
- Market Cap
- FTFT 6.2M
- APVO 5.4M
- IPO Year
- FTFT N/A
- APVO N/A
- Fundamental
- Price
- FTFT $0.24
- APVO $3.47
- Analyst Decision
- FTFT
- APVO Strong Buy
- Analyst Count
- FTFT 0
- APVO 1
- Target Price
- FTFT N/A
- APVO $296.00
- AVG Volume (30 Days)
- FTFT 320.7K
- APVO 44.0K
- Earning Date
- FTFT 04-15-2025
- APVO 03-04-2025
- Dividend Yield
- FTFT N/A
- APVO N/A
- EPS Growth
- FTFT N/A
- APVO N/A
- EPS
- FTFT N/A
- APVO N/A
- Revenue
- FTFT $18,543,659.00
- APVO N/A
- Revenue This Year
- FTFT N/A
- APVO N/A
- Revenue Next Year
- FTFT N/A
- APVO N/A
- P/E Ratio
- FTFT N/A
- APVO N/A
- Revenue Growth
- FTFT N/A
- APVO N/A
- 52 Week Low
- FTFT $0.23
- APVO $3.01
- 52 Week High
- FTFT $1.28
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- FTFT 40.48
- APVO 33.42
- Support Level
- FTFT $0.23
- APVO $3.20
- Resistance Level
- FTFT $0.28
- APVO $3.65
- Average True Range (ATR)
- FTFT 0.02
- APVO 0.34
- MACD
- FTFT 0.00
- APVO 0.01
- Stochastic Oscillator
- FTFT 13.20
- APVO 31.51
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.